Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Supriya Lifescience Ltd leads losers in 'A' group
PC Jeweller Ltd, Zensar Technologies Ltd, Ola Electric Mobility Ltd and Apollo Micro Systems Ltd are among the other losers in the BSE's 'A' group today, 06 July 2026.
Supriya Lifescience tanks 12%; why pharma stock under pressure?
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
Supriya Lifescience tanks 12%; what's ailing this pharma stock?
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
Supriya Lifescience drops after customs probe against senior executive under NDPS Act
Supriya Lifescience declined 5.64% to Rs 923.70 after the company disclosed that judicial proceedings have been initiated against a senior employee by the Special Investigation and Intelligence branch of the Customs Department.
Supriya Life says Customs dept initiates judicial proceedings against personnel under Narcotics Act
The company said the proceedings were initiated against Sreedharan under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 for a procedural lapse for a single export transaction of identified product for which the officer is under judicial detention.
Supriya Lifescience Ltd leads losers in 'A' group
Wockhardt Ltd, NHPC Ltd, Force Motors Ltd and RHI Magnesita India Ltd are among the other losers in the BSE's 'A' group today, 02 June 2026.
Supriya Lifescience Ltd leads gainers in 'A' group
Relaxo Footwears Ltd, Wockhardt Ltd, Netweb Technologies India Ltd and Ashapura Minechem Ltd are among the other gainers in the BSE's 'A' group today, 29 May 2026.
Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoY
Supriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surging 50%. Robust demand across therapeutic segments, improved capacity utilisation, and traction in regulated markets supported growth. The stock remains in an uptrend despite overbought technical indicators.
Supriya Lifescience soars after Q4 PAT jumps 47.4% YoY
Supriya Lifescience surged 18.06% to Rs 953.05 after the active pharmaceutical ingredients (API) manufacturer reported strong Q4 FY26 earnings.
Buy Siemens Energy, Supriya Lifescience, Exide Industries: Analyst
Stocks to buy: Kunal Kamble of Bonanza suggests buying Siemens Energy, Supriya Lifescience and Exide Industries
Supriya Lifescience standalone net profit rises 47.34% in the March 2026 quarter
Sales rise 50.20% to Rs 276.53 crore
eClerx Services Ltd leads gainers in 'A' group
Tanla Platforms Ltd, Coforge Ltd, Supriya Lifescience Ltd and Angel One Ltd are among the other gainers in the BSE's 'A' group today, 19 May 2026.